126 related articles for article (PubMed ID: 37339182)
1. The lncRNA LETS1 promotes TGF-β-induced EMT and cancer cell migration by transcriptionally activating a TβR1-stabilizing mechanism.
Fan C; González-Prieto R; Kuipers TB; Vertegaal ACO; van Veelen PA; Mei H; Ten Dijke P
Sci Signal; 2023 Jun; 16(790):eadf1947. PubMed ID: 37339182
[TBL] [Abstract][Full Text] [Related]
2. LncRNA LITATS1 suppresses TGF-β-induced EMT and cancer cell plasticity by potentiating TβRI degradation.
Fan C; Wang Q; Kuipers TB; Cats D; Iyengar PV; Hagenaars SC; Mesker WE; Devilee P; Tollenaar RAEM; Mei H; Ten Dijke P
EMBO J; 2023 May; 42(10):e112806. PubMed ID: 36994542
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA SMASR inhibits the EMT by negatively regulating TGF-β/Smad signaling pathway in lung cancer.
Xu L; Liu W; Li T; Hu Y; Wang Y; Huang L; Wang Y; Shao S; Liu X; Zhan Q
Oncogene; 2021 May; 40(20):3578-3592. PubMed ID: 33931741
[TBL] [Abstract][Full Text] [Related]
4. [Aberrant Activation Mechanism of TGF-β Signaling in Epithelial-mesenchymal Transition].
Yuki R
Yakugaku Zasshi; 2021; 141(11):1229-1234. PubMed ID: 34719542
[TBL] [Abstract][Full Text] [Related]
5. PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptors.
Liu C; Li J; Xiang X; Guo L; Tu K; Liu Q; Shah VH; Kang N
Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(7):G749-59. PubMed ID: 25169976
[TBL] [Abstract][Full Text] [Related]
6. Syntenin regulates TGF-β1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-β type I receptor internalization.
Hwangbo C; Tae N; Lee S; Kim O; Park OK; Kim J; Kwon SH; Lee JH
Oncogene; 2016 Jan; 35(3):389-401. PubMed ID: 25893292
[TBL] [Abstract][Full Text] [Related]
7. Transforming Growth Factor β/NR4A1-Inducible Breast Cancer Cell Migration and Epithelial-to-Mesenchymal Transition Is p38α (Mitogen-Activated Protein Kinase 14) Dependent.
Hedrick E; Safe S
Mol Cell Biol; 2017 Sep; 37(18):. PubMed ID: 28674186
[TBL] [Abstract][Full Text] [Related]
8. Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells.
Zhang J; Thorikay M; van der Zon G; van Dinther M; Ten Dijke P
J Vis Exp; 2020 Oct; (164):. PubMed ID: 33191940
[TBL] [Abstract][Full Text] [Related]
9. A short peptide encoded by long non-coding RNA small nucleolar RNA host gene 6 promotes cell migration and epithelial-mesenchymal transition by activating transforming growth factor-beta/SMAD signaling pathway in human endometrial cells.
Zou Q; Du X; Zhou L; Yao D; Dong Y; Jin J
J Obstet Gynaecol Res; 2023 Jan; 49(1):232-242. PubMed ID: 36396030
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-β-induced lncRNA-Smad7 inhibits apoptosis of mouse breast cancer JygMC(A) cells.
Arase M; Horiguchi K; Ehata S; Morikawa M; Tsutsumi S; Aburatani H; Miyazono K; Koinuma D
Cancer Sci; 2014 Aug; 105(8):974-82. PubMed ID: 24863656
[TBL] [Abstract][Full Text] [Related]
11. Opposing USP19 splice variants in TGF-β signaling and TGF-β-induced epithelial-mesenchymal transition of breast cancer cells.
Zhang J; van Dinther M; Thorikay M; Gourabi BM; Kruithof BPT; Ten Dijke P
Cell Mol Life Sci; 2023 Jan; 80(2):43. PubMed ID: 36646950
[TBL] [Abstract][Full Text] [Related]
12. ST3GAL5-catalyzed gangliosides inhibit TGF-β-induced epithelial-mesenchymal transition via TβRI degradation.
Zhang J; van der Zon G; Ma J; Mei H; Cabukusta B; Agaser CC; Madunić K; Wuhrer M; Zhang T; Ten Dijke P
EMBO J; 2023 Jan; 42(2):e110553. PubMed ID: 36504224
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.
Richards EJ; Zhang G; Li ZP; Permuth-Wey J; Challa S; Li Y; Kong W; Dan S; Bui MM; Coppola D; Mao WM; Sellers TA; Cheng JQ
J Biol Chem; 2015 Mar; 290(11):6857-67. PubMed ID: 25605728
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA
Sakai S; Ohhata T; Kitagawa K; Uchida C; Aoshima T; Niida H; Suzuki T; Inoue Y; Miyazawa K; Kitagawa M
Cancer Res; 2019 Jun; 79(11):2821-2838. PubMed ID: 30952633
[TBL] [Abstract][Full Text] [Related]
15. Prohaptoglobin inhibits the transforming growth factor-β-induced epithelial-to-mesenchymal transition in vitro by increasing Smad1/5 activation and suppressing the Smad2/3 signaling pathway in SK-Hep1 liver cancer cells.
Oh MK; Joo H; Kim IS
PLoS One; 2022; 17(5):e0266409. PubMed ID: 35580109
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA TUG1 can promote proliferation and migration of pancreatic cancer via EMT pathway.
Qin CF; Zhao FL
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2377-2384. PubMed ID: 28617552
[TBL] [Abstract][Full Text] [Related]
17. SMAD3/SP1 complex-mediated constitutive active loop between lncRNA PCAT7 and TGF-β signaling promotes prostate cancer bone metastasis.
Lang C; Dai Y; Wu Z; Yang Q; He S; Zhang X; Guo W; Lai Y; Du H; Wang H; Ren D; Peng X
Mol Oncol; 2020 Apr; 14(4):808-828. PubMed ID: 31925912
[TBL] [Abstract][Full Text] [Related]
18. ShcA Protects against Epithelial-Mesenchymal Transition through Compartmentalized Inhibition of TGF-β-Induced Smad Activation.
Muthusamy BP; Budi EH; Katsuno Y; Lee MK; Smith SM; Mirza AM; Akhurst RJ; Derynck R
PLoS Biol; 2015 Dec; 13(12):e1002325. PubMed ID: 26680585
[TBL] [Abstract][Full Text] [Related]
19. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
